Trial Profile
A phase I trial to evaluate the efficacy and safety of allogeneic bone marrow derived mesenchymal stem cell therapy in patients with diabetic retinopathy and diabetic optic neuropathy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 28 Mar 2016 New trial record